Investment Thesis
Enovix is a pre-commercialization battery technology company with negligible revenue ($7.6M) yet massive operating losses ($43.9M), resulting in severe negative cash flow (-$36.3M FCF) that depletes its $88.8M cash reserve within 2-3 years. The company carries substantial debt ($520.4M) with interest coverage of -6.3x, indicating inability to service debt from operations, while zero YoY revenue growth signals failure to accelerate commercialization.
Strengths
- Positive gross margin of 20.4% on commercialized products
- Strong liquidity with current ratio of 10.97x
- Moderate cash position of $88.8M provides near-term runway
Risks
- Operating losses of $43.9M vastly exceed $7.6M revenue base with -577.6% operating margin
- Negative free cash flow of -$36.3M annually indicates cash runway of ~2-3 years at current burn rate
- High leverage at 2.16x debt-to-equity with $520.4M long-term debt and inability to service debt from operations (interest coverage -6.3x)
- Zero YoY revenue growth indicates commercialization stalled without clear acceleration path to profitability
- 31 Form 4 insider filings in 90 days may signal distress or confidence uncertainty
Key Metrics to Watch
- Quarterly revenue growth rate and path to sustained positive YoY growth
- Operating cash flow trajectory and time to cash flow breakeven
- Cash burn rate and months of cash runway remaining
- Debt refinancing ability and debt service coverage improvement
Financial Metrics
Revenue
7.6M
Net Income
-38.3M
EPS (Diluted)
$-0.18
Free Cash Flow
-36.3M
Total Assets
833.9M
Cash
88.8M
Profitability Ratios
Gross Margin
20.4%
Operating Margin
-577.6%
Net Margin
-503.4%
ROE
-15.9%
ROA
-4.6%
FCF Margin
-477.5%
Balance Sheet & Liquidity
Current Ratio
10.97x
Quick Ratio
10.65x
Debt/Equity
2.16x
Debt/Assets
70.9%
Interest Coverage
-6.26x
Long-term Debt
520.4M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-15T06:26:29.927272 |
Data as of: 2026-04-05 |
Powered by Claude AI